Literature DB >> 31820016

[Advance Care Planning-further development of the patient advance directive : What the anesthetist must know].

S Petri1, B Zwißler2, J In der Schmitten3, B Feddersen4.   

Abstract

Despite the availability of the instruments of advance directives, power of attorney and healthcare proxy, the patient's preferences for life-sustaining medical treatment in a specific situation often remain unknown. The aim of the systemically designed German Advance Care Planning (ACP) program is the reflection, documentation and implementation of patients' preferences regarding future medical treatment in case they are incapable of legally binding decision-making. A specially trained ACP facilitator initially supports the verbalization of the attitudes towards life, severe illness and death on an individual level. Based on these principal views, concrete preferences on how to be treated under defined medical circumstances can be discussed and documented in an advance directive. This includes the three scenarios medical emergency, inpatient hospital treatment in situations with decisional incapability of unknown duration and the situation of permanent cognitive impairment. Through cautious, nondirective conversational techniques in the sense of shared decision-making, the person is enabled to reflect and decide well-informed according to the informed consent standard. All persons participating in decisions regarding future medical treatment, especially future surrogate decision makers, are involved in the process as early as possible. A systematic institutional and regional implementation of the concept is necessary to ensure that the carefully assessed and documented preferences of the patients will be known and honored. The new German § 132g of the Social Code Book V (SGB V) enables institutions for long-term care and for the care of disabled persons, to offer facilitated ACP to all residents at the expense of the statutory health insurance funds. An increased dissemination of this concept is to be expected.

Entities:  

Keywords:  Advance Care Planning; Emergency medicine; Informed consent; Intensive care; Shared decision making

Year:  2020        PMID: 31820016     DOI: 10.1007/s00101-019-00697-2

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  18 in total

Review 1.  Systematic review: the effect on surrogates of making treatment decisions for others.

Authors:  David Wendler; Annette Rid
Journal:  Ann Intern Med       Date:  2011-03-01       Impact factor: 25.391

Review 2.  [Documentation of decisions to withhold or withdraw life-sustaining therapies : Recommendation of the Ethics Section of the German Interdisciplinary Association of Critical Care and Emergency Medicine (DIVI) in collaboration with the Ethics Section of the German Society for Medical Intensive Care and Emergency Medicine (DGIIN)].

Authors:  G Neitzke; B Böll; H Burchardi; K Dannenberg; G Duttge; R Erchinger; P Gretenkort; C Hartog; K Knochel; M Liebig; A Michalsen; G Michels; M Mohr; F Nauck; P Radke; F Salomon; H Stopfkuchen; U Janssens
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-09       Impact factor: 0.840

3.  Implementing an advance care planning program in German nursing homes: results of an inter-regionally controlled intervention trial.

Authors:  Jürgen In der Schmitten; Katharina Lex; Christine Mellert; Sonja Rothärmel; Karl Wegscheider; Georg Marckmann
Journal:  Dtsch Arztebl Int       Date:  2014-01-24       Impact factor: 5.594

Review 4.  Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials.

Authors:  Joseph P Broderick; Opeolu Adeoye; Jordan Elm
Journal:  Stroke       Date:  2017-06-16       Impact factor: 7.914

Review 5.  Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care.

Authors:  Judith A C Rietjens; Rebecca L Sudore; Michael Connolly; Johannes J van Delden; Margaret A Drickamer; Mirjam Droger; Agnes van der Heide; Daren K Heyland; Dirk Houttekier; Daisy J A Janssen; Luciano Orsi; Sheila Payne; Jane Seymour; Ralf J Jox; Ida J Korfage
Journal:  Lancet Oncol       Date:  2017-09       Impact factor: 41.316

6.  [Advance directives in prehospital emergency treatment : prospective questionnaire-based analysis].

Authors:  J C Brokmann; T Grützmann; A K Pidun; D Groß; R Rossaint; S K Beckers; A T May
Journal:  Anaesthesist       Date:  2014-01-09       Impact factor: 1.041

Review 7.  [Advance Care Planning and its Relevance for Emergency and Intensive Care Medicine].

Authors:  Friedemann Nauck; Georg Marckmann; Jürgen In der Schmitten
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2018-01-10       Impact factor: 0.698

8.  Advance directives in nursing homes: prevalence, validity, significance, and nursing staff adherence.

Authors:  Sarah Sommer; Georg Marckmann; Michael Pentzek; Karl Wegscheider; Heinz-Harald Abholz; Jürgen in der Schmitten
Journal:  Dtsch Arztebl Int       Date:  2012-09-14       Impact factor: 5.594

9.  The impact of advance care planning on end of life care in elderly patients: randomised controlled trial.

Authors:  Karen M Detering; Andrew D Hancock; Michael C Reade; William Silvester
Journal:  BMJ       Date:  2010-03-23

10.  End-of-life decision-making in six European countries: descriptive study.

Authors:  Agnes van der Heide; Luc Deliens; Karin Faisst; Tore Nilstun; Michael Norup; Eugenio Paci; Gerrit van der Wal; Paul J van der Maas
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

View more
  2 in total

Review 1.  [Implementing patient-centered advance care planning in the outpatient setting during the COVID-19 pandemic].

Authors:  Berend Feddersen; Sabine Petri; Georg Marckmann; Jürgen In der Schmitten
Journal:  MMW Fortschr Med       Date:  2020-05

2.  "SpezPat"- common advance directives versus disease-centred advance directives: a randomised controlled pilot study on the impact on physicians' understanding of non-small cell lung cancer patients' end-of-life decisions.

Authors:  Julia Felicitas Leni Koenig; Thomas Asendorf; Alfred Simon; Annalen Bleckmann; Lorenz Truemper; Gerald Wulf; Tobias R Overbeck
Journal:  BMC Palliat Care       Date:  2022-09-28       Impact factor: 3.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.